Skip to main content
Erschienen in: Acta Neuropathologica 3/2009

01.03.2009 | Case Report

A patient with Huntington’s disease and long-surviving fetal neural transplants that developed mass lesions

verfasst von: C. Dirk Keene, Rubens C. Chang, James B. Leverenz, Oleg Kopyov, Susan Perlman, Robert F. Hevner, Donald E. Born, Thomas D. Bird, Thomas J. Montine

Erschienen in: Acta Neuropathologica | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Transplantation of human fetal neural tissue into adult neostriatum is an experimental therapy for Huntington’s disease (HD). Here we describe a patient with HD who received ten intrastriatal human fetal neural transplants and, at one site, an autologous sural nerve co-graft. Although initially clinically stable, she developed worsening asymmetric upper motor neuron symptoms in addition to progression of HD, and ultimately died 121 months post transplantation. Eight neural transplants, up to 2.9 cm, and three ependymal cysts, up to 2.0 cm, were identified. The autologous sural nerve co-graft was found adjacent to the largest mass lesion, which, along with the ependymal cyst, exhibited pronounced mass effect on the internal capsules bilaterally. Grafts were composed of neurons and glia embedded in disorganized neuropil; robust Y chromosome labeling was present in a subset of grafts and cysts. The graft–host border was discrete, and there was no evidence of graft rejection or HD pathologic changes within donor neurons. This report, for the first time, highlights the potential for graft overgrowth in a patient receiving fetal neural transplantation.
Literatur
1.
Zurück zum Zitat Bachoud-Lévi A, Bourdet C, Brugières P, Nguyen JP, Grandmougin T, Haddad B, Jény R, Bartolomeo P, Boissé MF, Barba GD, Degos JD, Ergis AM, Lefaucheur JP, Lisovoski F, Pailhous E, Rémy P, Palfi S, Defer GL, Cesaro P, Hantraye P, Peschanski M (2000) Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington’s disease. Exp Neurol 161:194–202. doi:10.1006/exnr.1999.7239 PubMedCrossRef Bachoud-Lévi A, Bourdet C, Brugières P, Nguyen JP, Grandmougin T, Haddad B, Jény R, Bartolomeo P, Boissé MF, Barba GD, Degos JD, Ergis AM, Lefaucheur JP, Lisovoski F, Pailhous E, Rémy P, Palfi S, Defer GL, Cesaro P, Hantraye P, Peschanski M (2000) Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington’s disease. Exp Neurol 161:194–202. doi:10.​1006/​exnr.​1999.​7239 PubMedCrossRef
2.
Zurück zum Zitat Bachoud-Lévi AC, Gaura V, Brugières P, Lefaucheur JP, Boissé MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, Remy P, Cesaro P, Hantraye P, Peschanski M (2006) Effect of fetal neural transplants in patients with Huntington’s disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 5:303–309. doi:10.1016/S1474-4422(06)70381-7 PubMedCrossRef Bachoud-Lévi AC, Gaura V, Brugières P, Lefaucheur JP, Boissé MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, Remy P, Cesaro P, Hantraye P, Peschanski M (2006) Effect of fetal neural transplants in patients with Huntington’s disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 5:303–309. doi:10.​1016/​S1474-4422(06)70381-7 PubMedCrossRef
3.
Zurück zum Zitat Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boissé MF, Grandmougin T, Jény R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M (2000) Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation. Lancet 356:1975–1979. doi:10.1016/S0140-6736(00)03310-9 PubMedCrossRef Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boissé MF, Grandmougin T, Jény R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M (2000) Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation. Lancet 356:1975–1979. doi:10.​1016/​S0140-6736(00)03310-9 PubMedCrossRef
4.
Zurück zum Zitat Collier TJ, Elsworth JD, Taylor JR, Sladek JR Jr, Roth RH, Redmond DE Jr (1994) Peripheral nerve-dopamine neuron co-grafts in MPTP-treated monkeys: augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systems. Neuroscience 61:875–879. doi:10.1016/0306-4522(94)90410-3 PubMedCrossRef Collier TJ, Elsworth JD, Taylor JR, Sladek JR Jr, Roth RH, Redmond DE Jr (1994) Peripheral nerve-dopamine neuron co-grafts in MPTP-treated monkeys: augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systems. Neuroscience 61:875–879. doi:10.​1016/​0306-4522(94)90410-3 PubMedCrossRef
6.
Zurück zum Zitat Folkerth RD, Durso R (1996) Survival and proliferation of non-neural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 46:1219–1225PubMed Folkerth RD, Durso R (1996) Survival and proliferation of non-neural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 46:1219–1225PubMed
7.
Zurück zum Zitat Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, Nauert GM, Sanberg PR, Kordower JH, Saporta S, Isacson O (2000) Transplanted fetal striatum in Huntington’s disease: phenotypic development and lack of pathology. Proc Natl Acad Sci USA 97:13877–13882. doi:10.1073/pnas.97.25.13877 PubMedCrossRef Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, Nauert GM, Sanberg PR, Kordower JH, Saporta S, Isacson O (2000) Transplanted fetal striatum in Huntington’s disease: phenotypic development and lack of pathology. Proc Natl Acad Sci USA 97:13877–13882. doi:10.​1073/​pnas.​97.​25.​13877 PubMedCrossRef
8.
Zurück zum Zitat Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S, Scott D, Nauert GM, Soety E, Sossi V, Holt DA, Sanberg PR, Stoessl AJ, Freeman TB (2002) Bilateral human fetal striatal transplantation in Huntington’s disease. Neurology 58:687–695PubMed Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S, Scott D, Nauert GM, Soety E, Sossi V, Holt DA, Sanberg PR, Stoessl AJ, Freeman TB (2002) Bilateral human fetal striatal transplantation in Huntington’s disease. Neurology 58:687–695PubMed
11.
Zurück zum Zitat Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med 14:504–506. doi:10.1038/nm1747 PubMedCrossRef Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med 14:504–506. doi:10.​1038/​nm1747 PubMedCrossRef
12.
Zurück zum Zitat Kordower JH, Freeman TB, Bakay RA, Goetz CG, Olanow CW (1997) Treatment with fetal allografts. Neurology 48:1737–1738PubMed Kordower JH, Freeman TB, Bakay RA, Goetz CG, Olanow CW (1997) Treatment with fetal allografts. Neurology 48:1737–1738PubMed
13.
Zurück zum Zitat Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P (2008) Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease progression. Nat Med 14:501–503. doi:10.1038/nm1746 PubMedCrossRef Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P (2008) Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease progression. Nat Med 14:501–503. doi:10.​1038/​nm1746 PubMedCrossRef
14.
Zurück zum Zitat Madrazo I, Franco-Bourland RE, Castrejon H, Cuevas C, Ostrosky-Solis F (1995) Fetal striatal homotransplantation for Huntington’s disease: first two case reports. Neurol Res 17:312–315PubMed Madrazo I, Franco-Bourland RE, Castrejon H, Cuevas C, Ostrosky-Solis F (1995) Fetal striatal homotransplantation for Huntington’s disease: first two case reports. Neurol Res 17:312–315PubMed
15.
Zurück zum Zitat Mamelak AN, Eggerding FA, Oh DS, Wilson E, Davis RL, Spitzer R, Hay JA, Caton WL 3rd (1998) Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson’s disease. J Neurosurg 89:592–598PubMedCrossRef Mamelak AN, Eggerding FA, Oh DS, Wilson E, Davis RL, Spitzer R, Hay JA, Caton WL 3rd (1998) Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson’s disease. J Neurosurg 89:592–598PubMedCrossRef
16.
Zurück zum Zitat Mendez I, Sanchez-Pernaute R, Cooper O, Viñuela A, Ferrari D, Björklund L, Dagher A, Isacson O (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson’s disease. Brain 128:1498–1510. doi:10.1093/brain/awh510 PubMedCrossRef Mendez I, Sanchez-Pernaute R, Cooper O, Viñuela A, Ferrari D, Björklund L, Dagher A, Isacson O (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson’s disease. Brain 128:1498–1510. doi:10.​1093/​brain/​awh510 PubMedCrossRef
17.
Zurück zum Zitat Mendez I, Vinuela A, Astradsson A, Mukhida K, Hallett P, Robertson H, Tierney T, Holness R, Dagher A, Trojanowski JQ, Isacson O (2008) Dopamine neurons implanted into people with Parkinson’s disease survive without pathology for 14 years. Nat Med 14:507–509. doi:10.1038/nm1752 PubMedCrossRef Mendez I, Vinuela A, Astradsson A, Mukhida K, Hallett P, Robertson H, Tierney T, Holness R, Dagher A, Trojanowski JQ, Isacson O (2008) Dopamine neurons implanted into people with Parkinson’s disease survive without pathology for 14 years. Nat Med 14:507–509. doi:10.​1038/​nm1752 PubMedCrossRef
19.
20.
Zurück zum Zitat Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K, Lindvall O, MacMillan J, Roos R (1996) Core assessment program for intracerebral transplantation in Huntington’s disease (CAPIT-HD). Mov Disord 11:143–150. doi:10.1002/mds.870110202 PubMedCrossRef Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K, Lindvall O, MacMillan J, Roos R (1996) Core assessment program for intracerebral transplantation in Huntington’s disease (CAPIT-HD). Mov Disord 11:143–150. doi:10.​1002/​mds.​870110202 PubMedCrossRef
21.
Zurück zum Zitat Ross BD, Hoang TO, Blüml S, Dubowitz D, Kopyov OV, Jacques DB, Lin A, Seymour K, Tan J (1999) In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR Biomed 12:221–236. doi:10.1002/(SICI)1099-1492(199906)12:4<221::AID-NBM582>3.0.CO;2-QPubMedCrossRef Ross BD, Hoang TO, Blüml S, Dubowitz D, Kopyov OV, Jacques DB, Lin A, Seymour K, Tan J (1999) In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR Biomed 12:221–236. doi:10.1002/(SICI)1099-1492(199906)12:4<221::AID-NBM582>3.0.CO;2-QPubMedCrossRef
22.
Zurück zum Zitat Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, Burnstein RM, Menon DK, Gillard JH, Pickard J, Dunnett SB, NEST-UK (2002) Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry 73:678–685. doi:10.1136/jnnp.73.6.678 PubMedCrossRef Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, Burnstein RM, Menon DK, Gillard JH, Pickard J, Dunnett SB, NEST-UK (2002) Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry 73:678–685. doi:10.​1136/​jnnp.​73.​6.​678 PubMedCrossRef
23.
Zurück zum Zitat Sramka M, Rattaj M, Molina H, Vojtassák J, Belan V, Ruzický E (1992) Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington’s chorea. Stereotact Funct Neurosurg 58:79–83. doi:10.1159/000098976 PubMedCrossRef Sramka M, Rattaj M, Molina H, Vojtassák J, Belan V, Ruzický E (1992) Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington’s chorea. Stereotact Funct Neurosurg 58:79–83. doi:10.​1159/​000098976 PubMedCrossRef
24.
Zurück zum Zitat Ulrisch R, Jacques S, Kopyov O (2000) Neural transplantation. J Neurosurg 93:163–164PubMed Ulrisch R, Jacques S, Kopyov O (2000) Neural transplantation. J Neurosurg 93:163–164PubMed
26.
27.
Zurück zum Zitat Watts RL, Subramanian T, Freeman A, Goetz CG, Penn RD, Stebbins GT, Kordower JH, Bakay RA (1997) Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson’s disease: two-year follow-up study. Exp Neurol 147:510–517. doi:10.1006/exnr.1997.6626 PubMedCrossRef Watts RL, Subramanian T, Freeman A, Goetz CG, Penn RD, Stebbins GT, Kordower JH, Bakay RA (1997) Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson’s disease: two-year follow-up study. Exp Neurol 147:510–517. doi:10.​1006/​exnr.​1997.​6626 PubMedCrossRef
Metadaten
Titel
A patient with Huntington’s disease and long-surviving fetal neural transplants that developed mass lesions
verfasst von
C. Dirk Keene
Rubens C. Chang
James B. Leverenz
Oleg Kopyov
Susan Perlman
Robert F. Hevner
Donald E. Born
Thomas D. Bird
Thomas J. Montine
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 3/2009
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-008-0465-0

Weitere Artikel der Ausgabe 3/2009

Acta Neuropathologica 3/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.